{
    "nctId": "NCT00671476",
    "briefTitle": "Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery",
    "officialTitle": "Intraductal Therapy of DCIS: A Presurgery Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Efficacy",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of ductal breast carcinoma in situ by core needle biopsy\n\n  * No pathological invasive or microinvasive disease in the affected breast\n* Mammographic microcalcifications are limited to one ductal system or one quadrant of breast\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n* Must be able to undergo necessary surgery\n* Not pregnant\n\nPRIOR CONCURRENT THERAPY:\n\n* No prior surgery or radiotherapy to the recently diagnosed breast\n* More than 12 months since prior chemotherapy\n* No prior subareolar breast surgery to the affected breast\n* Not concurrently involved in a research protocol for unapproved new drug evaluation",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}